Table 1.
Serum levels of plasma lipoproteins, uric acid, C-reactive protein and transaminase activities, assessed after 36 weeks of study.
| Parameters | Control (n = 6) |
AAB + SD (n = 8) |
AAB + HD (n = 8) |
AAB + HD + ALA (n = 9) |
|---|---|---|---|---|
| total Cholesterol (mg/dL) | 72.40 ± 4.31 | 69.13 ± 5.13 | 81.80 ± 6.68 | 71.86 ± 3.13 |
| LDL-Cholesterol (mg/dL) | 11.58 ± 1.06 | 12.83 ± 0.77 | 15.60 ± 1.68 | 11.63 ± 1.16 |
| HDL-Cholesterol (mg/dL) | 68.57 ± 4.29 | 64.80 ± 4.08 | 54.33 ± 4.22 # | 69.50 ± 2.78 & |
| Triglycerides (mg/dL) | 95.36 ± 11.80 | 90.00 ± 9.07 | 152.00 ± 22.27 ** | 87.00 ± 10.14 && |
| ASAT (U/L) | 142.63 ± 5.41 | 141.40 ± 7.01 | 139.00 ± 9.06 | 137.25 ± 17.97 |
| ALAT (U/L) | 39.13 ± 2.69 | 38.00 ± 3.89 | 42.33 ± 6.73 | 39.88 ± 3.84 |
| Uric acid (mg/dL) | 3.16 ± 0.25 | 2.48 ± 0.2 # | 2.03 ± 0.16 ## | 2.61 ± 0.23 & |
| C-reactive protein (mg/dL) | 0.46 ± 0.03 | 0.47 ± 0.01 | 0.49 ± 0.03 | 0.44 ± 0.02 |
| Creatinine (mg/dL) | 0.39 ± 0.01 | 0.37 ± 0.02 | 0.35 ± 0.01 # | 0.36 ± 0.05 |
#p < 0.05, ## p < 0.01: vs. Control; ** p < 0.01: vs. AAB + SD and Control; & p < 0.05, && p < 0.01: vs. AAB + HD (one-factor ANOVA).